Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Alza to market IVAX urology products in U.S., Canada

Sep. 30, 1997

Bosentan evaluated in humans for preventing ciclosporin nephrotoxicity

Sep. 29, 1997

Synaptic focuses on dihydropyrimidinones for BPH

Sep. 29, 1997

Sildenafil continues to demonstrate efficacy in treating ED

Sep. 26, 1997

Design, synthesis and evaluation of SNAP-5582 derivatives for BPH

Sep. 26, 1997

Synaptic identifies potent, selective alpha1a-adrenoceptor antagonist

Sep. 25, 1997

RenaGel safely and effectively binds phosphate in volunteers

Sep. 24, 1997

Cytoclonal allowed U.S. patent for PKD treatment

Sep. 23, 1997

Abbott investment to fund lupus drug candidate

Sep. 19, 1997

Efficacy of GAX-65 demonstrated in pediatric study

Sep. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...